The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections ...

The company produces and sells Omnipod, an automated insulin delivery device, which works without the need for external ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...

A reduced-calorie diet can help pregnant women who develop gestational diabetes avoid the need for insulin injections, ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Patients visiting clinics across multiple hospitals are facing severe difficulties due to an insufficient supply of insulin, chairman of the Doctors’ Trade Union Alliance for Medical and Civil Rights, ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.